$2.71
0.031.12%
al cierre: -
$2.68
-0.03-1.11%
After hour: Oct 24, 4:04 PM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Esperion Therapeutics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-0.070
Estimación de ingresos trimestrales
$95.94M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$268.13M
Analice el historial de beneficios de Esperion Therapeutics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
ESPR | Esperion Therapeutics | -$0.15 | -$0.07 | — | — | $51.63M | $95.94M | — | — | 11/06/2025 | |
ESPR | Esperion Therapeutics | -$0.33 | -$0.16 | -$0.02 | 87.50% | $73.83M | $64.35M | $82.39M | 28.04% | 08/05/2025 | |
ESPR | Esperion Therapeutics | $0.34 | -$0.15 | -$0.21 | -40.00% | $137.74M | $54.19M | $65.00M | 19.94% | 05/06/2025 | |
ESPR | Esperion Therapeutics | -$0.50 | -$0.16 | -$0.11 | 31.25% | $32.25M | $61.58M | $69.11M | 12.23% | 03/04/2025 | |
ESPR | Esperion Therapeutics | -$0.37 | -$0.18 | -$0.15 | 16.67% | $33.97M | $51.32M | $51.63M | 0.61% | 11/07/2024 | |
ESPR | Esperion Therapeutics | -$0.46 | -$0.15 | -$0.05 | 66.67% | $25.79M | $50.59M | $73.83M | 45.95% | 08/12/2024 | |
ESPR | Esperion Therapeutics | -$0.79 | $0.05 | $0.34 | 580.00% | $24.33M | $84.51M | $137.74M | 62.98% | 05/07/2024 | |
ESPR | Esperion Therapeutics | -$0.76 | -$0.48 | -$0.50 | -4.17% | $18.82M | $28.70M | $32.25M | 12.37% | 02/27/2024 | |
ESPR | Esperion Therapeutics | -$0.81 | -$0.43 | -$0.37 | 13.95% | $18.98M | $29.58M | $33.97M | 14.84% | 11/07/2023 | |
ESPR | Esperion Therapeutics | -$1.05 | -$0.63 | -$0.46 | 26.98% | $18.84M | $25.50M | $25.79M | 1.12% | 08/01/2023 | |
ESPR | Esperion Therapeutics | -$0.93 | -$0.65 | -$0.79 | -21.54% | $18.84M | $22.01M | $24.33M | 10.54% | 05/09/2023 | |
ESPR | Esperion Therapeutics | -$1.77 | -$0.84 | -$0.76 | 9.52% | $15.40M | $20.85M | $18.82M | -9.75% | 02/21/2023 | |
ESPR | Esperion Therapeutics | -$2.62 | -$0.93 | -$0.81 | 12.90% | $14.41M | $19.74M | $18.98M | -3.85% | 11/01/2022 | |
ESPR | Esperion Therapeutics | -$1.67 | -$0.93 | -$1.05 | -12.90% | $40.66M | $18.71M | $18.84M | 0.70% | 08/02/2022 | |
ESPR | Esperion Therapeutics | -$3.50 | -$1.04 | -$0.93 | 10.58% | $7.98M | $15.39M | $18.84M | 22.39% | 05/03/2022 | |
ESPR | Esperion Therapeutics | -$3.89 | -$2.27 | -$1.77 | 22.03% | $9.64M | $14.47M | $15.40M | 6.43% | 02/22/2022 | |
ESPR | Esperion Therapeutics | -$3.07 | -$2.79 | -$2.62 | 6.09% | $3.83M | $12.85M | $14.41M | 12.13% | 11/02/2021 | |
ESPR | Esperion Therapeutics | $4.32 | -$1.84 | -$1.67 | 9.24% | $212.24M | $42.27M | $40.66M | -3.81% | 08/03/2021 | |
ESPR | Esperion Therapeutics | -$2.84 | -$2.52 | -$3.50 | -38.89% | $1.84M | $26.12M | $7.98M | -69.46% | 05/04/2021 | |
ESPR | Esperion Therapeutics | -$2.26 | -$3.76 | -$3.89 | -3.46% | $982.00K | $12.52M | $9.64M | -23.02% | 02/23/2021 | |
ESPR | Esperion Therapeutics | -$2.52 | -$3.41 | -$3.07 | 9.97% | $981.00K | $5.93M | $3.83M | -35.36% | 11/02/2020 |
Esperion Therapeutics (ESPR) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $-0.02 | $-0.16 | 87.5 % |
| Q1 | 2025-05-06 | $-0.21 | $-0.15 | -40.0 % |
| Q4 | 2025-03-04 | $-0.11 | $-0.16 | 31.3 % |
| Q3 | 2024-11-07 | $-0.15 | $-0.18 | 16.7 % |
Esperion Therapeutics (ESPR) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-05 | $82.39M | $64.35M | 28.0 % |
| Q1 | 2025-05-06 | $65.00M | $54.19M | 19.9 % |
| Q4 | 2025-03-04 | $69.11M | $61.58M | 12.2 % |
| Q3 | 2024-11-07 | $51.63M | $51.32M | 0.61 % |
PREGUNTAS FRECUENTES
¿Cuándo Esperion Therapeutics (NASDAQ:ESPR) publicará los resultados?
Está previsto que Esperion Therapeutics (ESPR) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 5, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Esperion Therapeutics (NASDAQ:ESPR)?
El BPA real fue de $-0.02, que superó la estimación de $-0.16.
¿Cuáles fueron los ingresos de Esperion Therapeutics (NASDAQ:ESPR)?
Los ingresos reales fueron $82.4M, que superó la estimación de $64.3M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.